Heart Failure
NICE guidance
NG106: Chronic heart failure in adults: diagnosis and management, September 2018
TA1121 Acoramidis for treating transthyretin amyloidosis with cardiomyopathy, January 2026 - via tertiary services only
TA1115 Vutrisiran for treating transthyretin amyloidosis with cardiomyopathy - via tertiary services only
- Potassium-Sparing Diuretics (Aldosterone antagonists)
- Drugs Acting on the Renin-Angiotensin System
- Cardiogenic Shock
- SGLT2 Inhibitor (Heart Failure)
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary